miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1

Fei Lu(Peking University Shenzhen Hospital), Chunyan Ji(Qilu Hospital of Shandong University)
International Journal of Oncology
April 16, 2014
Cited by 90


Related Papers